We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




X-Ray Studies of Two Million-Year-Old Fossil Reveal Earliest Known Cancer

By HospiMedica International staff writers
Posted on 13 Sep 2016
The results of two studies carried out in South Africa, and in the UK, suggest that a hominid who lived between 1.6 million to 1.8 million years ago, had a potentially-fatal bone cancer.

While longer life spans, the use of pesticides, and other factors are causing an increase in the prevalence of cancer cases and tumor rates in modern society, the research shows that cancers and tumors also occurred in our ancestors living millions of years ago.

The results of the studies were published in the September 3, 2016, issue of ScienceNews. More...
In the first study, the hominid, either a member of the Homo genus or from the genus Paranthropus suffered from a malignant and possibly fatal, fast-growing cancer on a bone. The researchers used advanced X-Ray techniques and 3D representations to identify the cancer on the fossil-bone remains of the hominid found at the South African Swartkrans Cave site. The cancer was located on the surface of the toe, and in the bone.

In the second study, researchers found a benign tumor in the fossilized bone of an Australopithecus sediba child, nearly 2 million years old from an underground cave at the Malapa site also in South Africa.

Coauthor of both studies, medical anthropologist, Edward Odes, from the University of the Witwatersrand (Johannesburg, South Africa), said, “Our studies show that cancers and tumors occurred in our ancient relatives millions of years before modern industrial societies existed.”

Related Links:
University of the Witwatersrand


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Hybrid Arch Device
Neo EDE
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.